• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于入院生命体征指数预测重症 COVID-19 肺炎患者的死亡率:一项回顾性队列研究。

Predicting mortality among patients with severe COVID-19 pneumonia based on admission vital sign indices: a retrospective cohort study.

机构信息

Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Hat Yai, Songkhla, 90110, Thailand.

Critical Care Medicine Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Hat Yai, Songkhla, 90110, Thailand.

出版信息

BMC Pulm Med. 2023 Sep 12;23(1):342. doi: 10.1186/s12890-023-02643-w.

DOI:10.1186/s12890-023-02643-w
PMID:37700259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10496301/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) pneumonia remains a major public health concern. Vital sign indices-shock index (SI; heart rate [HR]/systolic blood pressure [SBP]), shock index age (SIA, SI × age), MinPulse (MP; maximum HR-HR), Pulse max index (PMI; HR/maximum HR), and blood pressure-age index (BPAI; SBP/age)-are better predictors of mortality in patients with trauma compared to traditional vital signs. We hypothesized that these vital sign indices may serve as predictors of mortality in patients with severe COVID-19 pneumonia. This study aimed to describe the association between vital sign indices at admission and COVID-19 pneumonia mortality and to modify the CURB-65 with the best performing vital sign index to establish a new mortality prediction tool.

METHODS

This retrospective study was conducted at a tertiary care center in southern Thailand. Adult patients diagnosed with COVID-19 pneumonia were enrolled in this study between January 2020 and July 2022. Patient demographic and clinical data on admission were collected from an electronic database. The area under the receiver operating characteristic (AUC) curve analysis was used to assess the predictive power of the resultant multivariable logistic regression model after univariate and multivariate analyses of variables with identified associations with in-hospital mortality.

RESULTS

In total, 251 patients with COVID-19 pneumonia were enrolled in this study. The in-hospital mortality rate was 27.9%. Non-survivors had significantly higher HR, respiratory rate, SIA, and PMI and lower MP and BPAI than survivors. A cutoff value of 51 for SIA (AUC, 0.663; specificity, 80%) was used to predict mortality. When SIA was introduced as a modifier for the CURB-65 score, the new score (the CURSIA score) showed a higher AUC than the Acute Physiology and Chronic Health Evaluation II and CURB-65 scores (AUCs: 0.785, 0.780, and 0.774, respectively) without statistical significance.

CONCLUSIONS

SIA and CURSIA scores were significantly associated with COVID-19 pneumonia mortality. These scores may contribute to better patient triage than traditional vital signs.

摘要

背景

2019 年冠状病毒病(COVID-19)肺炎仍然是一个主要的公共卫生关注点。生命体征指数-休克指数(SI;心率[HR]/收缩压[SBP])、休克指数年龄(SIA,SI×年龄)、最小脉搏(MP;最大 HR-HR)、脉搏最大指数(PMI;HR/最大 HR)和血压年龄指数(BPAI;SBP/年龄)-在预测创伤患者死亡率方面优于传统生命体征。我们假设这些生命体征指数可能是预测严重 COVID-19 肺炎患者死亡率的指标。本研究旨在描述入院时生命体征指数与 COVID-19 肺炎死亡率之间的关系,并使用表现最佳的生命体征指数对 CURB-65 进行修正,以建立新的死亡率预测工具。

方法

本回顾性研究在泰国南部的一家三级护理中心进行。本研究纳入了 2020 年 1 月至 2022 年 7 月期间被诊断患有 COVID-19 肺炎的成年患者。从电子数据库中收集患者入院时的人口统计学和临床数据。在对与住院死亡率有确定关联的变量进行单变量和多变量分析后,使用受试者工作特征(ROC)曲线下面积分析评估多变量逻辑回归模型的预测能力。

结果

本研究共纳入 251 例 COVID-19 肺炎患者。住院死亡率为 27.9%。与幸存者相比,非幸存者的 HR、呼吸频率、SIA 和 PMI 显著更高,而 MP 和 BPAI 显著更低。SIA 的截断值为 51(AUC,0.663;特异性,80%),用于预测死亡率。当 SIA 作为 CURB-65 评分的修正因子引入时,新评分(CURSIA 评分)的 AUC 高于急性生理学和慢性健康评估 II 和 CURB-65 评分(AUC 分别为 0.785、0.780 和 0.774),但无统计学意义。

结论

SIA 和 CURSIA 评分与 COVID-19 肺炎死亡率显著相关。这些评分可能比传统生命体征更有助于患者分诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/88df1571728a/12890_2023_2643_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/f5500dedd133/12890_2023_2643_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/a5385e34912f/12890_2023_2643_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/88df1571728a/12890_2023_2643_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/f5500dedd133/12890_2023_2643_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/a5385e34912f/12890_2023_2643_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b31/10496301/88df1571728a/12890_2023_2643_Fig3_HTML.jpg

相似文献

1
Predicting mortality among patients with severe COVID-19 pneumonia based on admission vital sign indices: a retrospective cohort study.基于入院生命体征指数预测重症 COVID-19 肺炎患者的死亡率:一项回顾性队列研究。
BMC Pulm Med. 2023 Sep 12;23(1):342. doi: 10.1186/s12890-023-02643-w.
2
The value of traditional vital signs, shock index, and age-based markers in predicting trauma mortality.传统生命体征、休克指数和基于年龄的标志物在预测创伤死亡率中的价值。
J Trauma Acute Care Surg. 2013 Jun;74(6):1432-7. doi: 10.1097/TA.0b013e31829246c7.
3
Vital sign based shock scores are poor at triaging South African trauma patients.基于生命体征的创伤评分在分诊南非创伤患者方面效果不佳。
Am J Surg. 2018 Aug;216(2):235-239. doi: 10.1016/j.amjsurg.2017.07.025. Epub 2017 Aug 30.
4
Pneumonia severity indices predict prognosis in coronavirus disease-2019.肺炎严重指数可预测 2019 冠状病毒疾病患者的预后。
Respir Med Res. 2021 May;79:100826. doi: 10.1016/j.resmer.2021.100826. Epub 2021 Apr 27.
5
Circadian rhythms of vital signs are associated with in-hospital mortality in critically ill patients: A retrospective observational study.生命体征的昼夜节律与危重症患者的院内死亡率相关:一项回顾性观察研究。
Chronobiol Int. 2023 Mar;40(3):262-271. doi: 10.1080/07420528.2022.2163656. Epub 2023 Jan 3.
6
Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study.入院生命体征预测 COVID-19 死亡率:一项回顾性横断面研究。
BMC Emerg Med. 2022 Apr 29;22(1):68. doi: 10.1186/s12873-022-00631-7.
7
Performance and comparison of assessment models to predict 30-day mortality in patients with hospital-acquired pneumonia.预测医院获得性肺炎患者30天死亡率的评估模型的性能与比较
Chin Med J (Engl). 2020 Dec 3;133(24):2947-2952. doi: 10.1097/CM9.0000000000001252.
8
[A new score system for prediction of death in patients with severe trauma: the value of death warning score].[一种用于预测严重创伤患者死亡的新评分系统:死亡预警评分的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Nov;27(11):890-4.
9
Platelet-to-White Blood Cell Ratio as a Predictor of Mortality in Patients with Severe COVID-19 Pneumonia: A Retrospective Cohort Study.血小板与白细胞比值作为重症新型冠状病毒肺炎患者死亡率的预测指标:一项回顾性队列研究
Infect Drug Resist. 2023 Jan 24;16:445-455. doi: 10.2147/IDR.S398731. eCollection 2023.
10
Comparison Between Physiological Scores SIPF, CURB-65, and APACHE II as Predictors of Prognosis and Mortality in Hospitalized Patients with COVID-19 Pneumonia: A Multicenter Study, Saudi Arabia.沙特阿拉伯多中心研究:生理评分SIPF、CURB-65和APACHE II作为COVID-19肺炎住院患者预后和死亡率预测指标的比较
Infect Drug Resist. 2022 Dec 23;15:7619-7630. doi: 10.2147/IDR.S395095. eCollection 2022.

引用本文的文献

1
Prognostic value of novel indices combining Shock Index, Reverse Shock Index, age, and oxygen saturation for predicting mortality in COVID-19 patients in Iran at emergency department triage: a cross-sectional study.急诊科分诊时,新型指标(结合休克指数、反向休克指数、年龄和血氧饱和度)对预测伊朗COVID-19患者死亡率的预后价值:一项横断面研究。
Acute Crit Care. 2025 Aug;40(3):425-434. doi: 10.4266/acc.005040. Epub 2025 Aug 29.
2
Percent Pulmonary Damage on Hospital Admission is Predictive of COVID-19 Aggravation, but Serum Protein Electrophoresis is Not.入院时肺部损伤百分比可预测新冠病毒疾病(COVID-19)病情加重,但血清蛋白电泳则不然。
J Glob Infect Dis. 2025 Jun 26;17(2):87-92. doi: 10.4103/jgid.jgid_93_24. eCollection 2025 Apr-Jun.
3

本文引用的文献

1
A new predictive tool consolidating CURB-65 with procalcitonin and albumin to assess short-term mortality in hospitalized elderly patients with infectious disease: A retrospective study of a patient cohort.一种新的预测工具,将 CURB-65 与降钙素原和白蛋白相结合,以评估住院老年传染病患者的短期死亡率:一项回顾性队列研究。
Medicine (Baltimore). 2022 Nov 18;101(46):e31614. doi: 10.1097/MD.0000000000031614.
2
Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study.入院生命体征预测 COVID-19 死亡率:一项回顾性横断面研究。
BMC Emerg Med. 2022 Apr 29;22(1):68. doi: 10.1186/s12873-022-00631-7.
3
Fungal Pulmonary Coinfections in COVID-19: Microbiological Assessment, Inflammatory Profiles, and Clinical Outcomes.COVID-19患者的真菌肺部合并感染:微生物学评估、炎症特征及临床结局
Biomedicines. 2025 Apr 3;13(4):864. doi: 10.3390/biomedicines13040864.
4
Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase.新型冠状病毒肺炎患者的免疫球蛋白:从急性期到恢复期。
Eur J Med Res. 2024 Apr 6;29(1):223. doi: 10.1186/s40001-024-01824-5.
Heart-rate-variability (HRV), predicts outcomes in COVID-19.
心率变异性(HRV)可预测 COVID-19 的结局。
PLoS One. 2021 Oct 28;16(10):e0258841. doi: 10.1371/journal.pone.0258841. eCollection 2021.
4
Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study.严重 COVID-19 肺炎患者死亡的预测因素——一项回顾性研究。
Adv Respir Med. 2021;89(2):135-144. doi: 10.5603/ARM.a2021.0036.
5
Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation.序贯器官衰竭评估评分对预测 COVID-19 肺炎机械通气患者病死率的判别准确性。
JAMA. 2021 Apr 13;325(14):1469-1470. doi: 10.1001/jama.2021.1545.
6
Shock index as a predictor of mortality among the Covid-19 patients.休克指数作为新冠病毒肺炎患者死亡率的预测指标。
Am J Emerg Med. 2021 Feb;40:106-109. doi: 10.1016/j.ajem.2020.12.053. Epub 2020 Dec 23.
7
Vital signs assessed in initial clinical encounters predict COVID-19 mortality in an NYC hospital system.初始临床接触中评估的生命体征可预测纽约市医院系统中 COVID-19 的死亡率。
Sci Rep. 2020 Dec 9;10(1):21545. doi: 10.1038/s41598-020-78392-1.
8
Clinical manifestations of COVID-19 in the general population: systematic review.普通人群中 COVID-19 的临床表现:系统评价。
Wien Klin Wochenschr. 2021 Apr;133(7-8):377-382. doi: 10.1007/s00508-020-01760-4. Epub 2020 Nov 26.
9
CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.CURB-65 可能是中国武汉 COVID-19 患者有用的预后标志物:一项回顾性队列研究。
Epidemiol Infect. 2020 Oct 1;148:e241. doi: 10.1017/S0950268820002368.
10
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.